DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation

Parainfluenza virus (PIV) may cause life-threatening pneumonia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Currently, there are no proven effective therapies. We report the use of inhaled DAS181, a novel sialidase fusion protein, for treatment of PIV type 3 pneumonia in two a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhakal, B., D'Souza, A., Pasquini, M., Saber, W., Fenske, T. S., Moss, R. B., Drobyski, W. R., Hari, P., Abidi, M. Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749780/
https://www.ncbi.nlm.nih.gov/pubmed/26941799
http://dx.doi.org/10.1155/2016/8503275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749780/
https://www.ncbi.nlm.nih.gov/pubmed/26941799
http://dx.doi.org/10.1155/2016/8503275

Ejemplares similares